These studies support the hypothesis that hyperoxia is an effect of MV and that NRF2 activation protects the lungs from VILI and ALI by inducing the transcription of antioxidant proteins and by downregulating NF-κB signaling46, 48, consistent with our results. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.